US Stock MarketDetailed Quotes

MOH Molina Healthcare

Watchlist
  • 298.310
  • +3.820+1.30%
Close Jan 6 16:00 ET
  • 297.010
  • -1.300-0.44%
Pre 08:22 ET
17.06BMarket Cap15.17P/E (TTM)

Molina Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Molina Healthcare Q4 2024 Estimates Date

Currency：USDFeb 5, 2025

Estimate YoY
Revenue
10.32B
+14.05%
EPS
5.53
+49.44%
Analyst Rating
Buy

Jan 6, 2025

Molina Healthcare Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.523B--
Feb 5, 20252024/Q4-- / 10.319B--
Oct 23, 20242024/Q310.340B / 9.917B--
Jul 24, 20242024/Q29.880B / 9.754B--
Apr 24, 20242024/Q19.931B / 9.433B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.523B--
Feb 5, 20252024/Q4-- / 10.319B--
Oct 23, 20242024/Q310.340B / 9.917B--
Jul 24, 20242024/Q29.880B / 9.754B--
Apr 24, 20242024/Q19.931B / 9.433B--

Unlock Free Earnings Estimates

Molina Healthcare Earnings Reports

  • Molina Healthcare | 10-Q: Q3 2024 Earnings Report

    Oct 24, 2024 10:39 ET

  • Molina Healthcare | 8-K: Molina Healthcare Reports Third Quarter 2024 Financial Results

    Oct 23, 2024 16:21 ET

  • Molina Healthcare | 10-Q: Q2 2024 Earnings Report

    Jul 25, 2024 11:43 ET

  • Molina Healthcare | 8-K: Molina Healthcare Reports Second Quarter 2024 Financial Results

    Jul 24, 2024 16:23 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Halozyme Therapeutics
    HALO
    +5.80%
    Hutchmed (China)
    HCM
    +5.47%
    Lantheus
    LNTH
    +2.86%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +2.31%
    Teradata Corp
    TDC
    +2.26%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 6, 2025

    Buy

    • Buy

      41.67%

    • Hold

      50.00%

    • Sell

      8.33%

    Price Target

    No Data